Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey

Mehmet Sinan Dal, Bahar Uncu Ulu, Ant Uzay, Olga Meltem Akay, Sevgi Kalayoğlu Beşışık, Mustafa Nuri Yenerel, Serhat Çelik, Leylagül Kaynar, Orhan Kemal Yücel, Burak Devecı, Mehmet Sönmez, Özgür Mehtap, Hüseyin Saffet Beköz, Cenk Sunu, Ozan Salim, Turgay Ulaş, Sami Kartı, Fevzi Altuntaş, Burhan Ferhanoğlu, Tülin Fırat Tuğlular